vigabatrin - oral
GENERIC NAME: VIGABATRIN - ORAL (vye-GA-ba-trin)
WARNING: Serious vision problems may occur while taking this medication and may be permanent even after you stop taking the medication. To prevent vision problems from getting worse, your doctor must find any eye problems as early as possible. Also, tell your doctor if you have a history of vision problems. It is very important that you have an eye exam before starting this medication, 4 weeks later, then every 3 months thereafter while you are taking this medication. You should also have an eye exam 3 to 6 months after stopping this medication. Follow your doctor's directions carefully and keep all medical/eye/lab appointments. Tell your doctor immediately if you have any changes in vision (such as loss of vision, blurred vision, double vision, sensitivity to light, eye pain).
Only patients who have signed an informed consent and agree to the requirements of the SHARE program (Support, Help and Resources for Epilepsy-SHARE) may obtain and use vigabatrin. Only physicians enrolled in SHARE may prescribe vigabatrin, and only pharmacies enrolled in the program may dispense it. Consult your doctor or pharmacist for more details about the SHARE program and for more information about the risk and benefits of using this medication. These requirements apply in the United States. If you live in Canada or any other country, consult your doctor and pharmacist for your country's regulations.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index